Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
321.00    -4.00 (-1.23%)
Bid:
314.00
Ask:
328.00
Spread: 14.00 (4.459%)
Market Cap: £40.73m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

16 Mar 2026 07:00

RNS Number : 7155W
System1 Group PLC
16 March 2026
 

 

 

 

 16 March 2026

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

Trading Update

Strong new business performance positions the Group for record H2 FY26 revenue and a return to profitable growth in FY27, ahead of market expectations

 

System1 www.system1group.com the marketing decision-making platform is pleased to provide an update on trading for the financial year ending 31 March 2026 and the outlook for FY27.

 

The Company has continued to trade strongly in the final quarter and, as a result, expects to report record H2 revenue and a performance for FY26 in line with guidance.

 

The strong level of new business wins secured throughout FY26 and particularly in the final quarter, provide a positive outlook for FY27.

 

After a period of additional investment, the business is delivering a cost optimisation and efficiency plan, including changes to the Group's organisational structure, sales incentivisation and go-to-market approach. This restructuring of the cost base, while incurring one-off costs in FY26, will provide for greater operational leverage as the Group's revenue growth rate increases. Further detail will be provided in the full-year results announcement.

 

As a result of the above, the Board remains comfortable with consensus Revenue forecasts for FY27 but now expects FY27 Adjusted EBITDA to be materially ahead of current market forecasts, with an Adjusted EBITDA margin of no less than 15% and the opportunity for further margin expansion as revenue scales.

 

The Board expects to publish the Group's FY26 trading update in late April 2026 and financial results in July 2026.

 

Commenting on the trading update, CEO James Gregory said: "The strategic progress we highlighted in our Interim Results, in Innovation, the USA, and with the world's largest brands, has continued to strengthen through the final quarter. The step up in new business wins, together with the completion of our investment phase and the benefits of cost optimisation activities, are now driving clearer commercial momentum and revenue growth, including double-digit growth in Innovation sales, deepening our customer engagement and strategic relevance. As we look to FY27, we are well positioned to scale our platform further, deepen client relationships, grow faster, and deliver profitability ahead of current market expectations."

 

Chairman Rupert Howell said: "It is gratifying to see the strategic growth initiatives delivering such positive, early results. System1 now has a strong and unified leadership team, with highly motivated staff to take the business on a pathway to double digit revenue growth, whilst managing costs to deliver improved margin growth. We are confident we have the right offering, team and strategy to deliver increased shareholder value in the years ahead."

 

Notes

For the purpose of this announcement, the guidance provided in the 23 September 2025 announcement was for FY26 Revenue to be broadly in line with the £37m achieved in FY25, and Adjusted Profit beforeTaxation in a range between £2.0 to £2.5 million. Adjusted Profit is Profit before Taxation excluding share-based payments.

For the purpose of this announcement, consensus FY27 Revenue is £38.8 million and Adjusted EBITDA is £4.3m. Adjusted EBITDA is Adjusted Profit before Taxation plus interest, depreciation and amortisation

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

 

System1 Group PLC

via Alma

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited (Nominated Adviser & Broker)

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

Singer Capital Markets (Joint Broker)

Tel: +44 (0) 20 7496 3000 

James Moat / James Fischer / Sara Hale

Alma Strategic Communications

Caroline Forde / Rebecca Sanders-Hewett / Robyn Fisher

Tel: +44 (0)20 3405 0205

System1@almastrategic.com 

 

About System1 Group plc

System1 is a marketing decision-making platform business, utilised by some of the world's largest brands, across 81 markets globally. Since 2000, System1 has helped marketers tap into consumers' emotions to predict and improve the commercial impact of ads and ideas. Drawing on the world's largest database of emotional norms, our advertising and idea tests measure emotion to give our customers the most accurate predictions of the business impact of creativity. We 'predict' (provide research results) and work with our customers and 'improve' (provide insight and consultancy on those results) advertising effectiveness, innovation effectiveness and brand effectiveness. 

 

We work for more than 500 customers, including 5 of the top 10 US and 8 of the top 10 UK advertisers. Customers include Pfizer, Amazon, TikTok, Sky, Lego, Pladis and Natura.

 

Further information on the Company can be found at www.system1group.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVAKRNAUOAAR
Date   Source Headline
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.